The multi-parameter combination, including MetS, NT-proBNP, smoking, and Gensini score showed a sensitivity of 81.7% and specificity of 78.3% to predict the decreased LV GLPS [AUC = 0.88; 95% CI (0.83–0.94)]. This evidence concerns the gene NPPB and metabolic syndrome.